Mt
Microneedle & Transdermal Delivery
011From pre-IND stages through commercialization, we have the expertise to help navigate the complex regulatory environment for microbiological control of microneedles and other novel transdermal products.
Ways we can help:
- Identifying appropriate microbial control specifications (CDER/CBER/CDRH).
- Pre IND communications.
- EOP2 meetings and planning for commercialization.
- Negotiating specifications/release testing.
- Document preparation.
- Generating product-specific microbial data.
- Applying USP methods/suitability studies.
- Method development/validation.
- Marketing submissions.
Annex 1 revision experts.
Our consultants are highly-recognized for their Annex 1 knowledge and expertise. We provide a plan forward through Annex 1 updates, today and into the future.